IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enliven Therapeutics Inc - US

CUSIP: 29337E110 | 1 institutional holders

Quarters

Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

Tudor Investment Corp ET AL9,506
0.0% of portfolio›$242.8K
StyleTurnoverLocationFiled
Tudor Investment Corp ET AL
9,506$242.8K0.0%CoreHighStamford, CT2024-11-14